Filter
118
Text search:
delamanid
Featured
Recommendations
23
New Publications
34
Language
Document type
No document type
79
Guidelines
17
Studies & Reports
8
Manuals
7
Fact sheets
3
Training Material
2
Situation Updates
2
Countries / Regions
Western and Central Europe
14
Eastern Europe
11
Germany
4
India
2
South Africa
2
Bolivia
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Asia
2
Russia
2
Ethiopia
1
Turkey
1
Malawi
1
Namibia
1
Botswana
1
Latin America and the Carribbean
1
Paraguay
1
Tajikistan
1
Estonia
1
Romania
1
Georgia
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
33
Countries
16
Pharmacy & Technologies
3
Public Health
1
Key Resources
1
Toolboxes
TB
102
HIV
5
Pharmacy
4
Caregiver
2
Ebola
1
Polio
1
Refugee
1
Global Health Education
1
AMR
1
COVID-19
1
Elaborat în cadrul proiectului „Fortificarea controlului tuberculozei în Moldova”, finanţat de către
Fondul Global de combatere a SIDA, Tuberculozei şi Malariei.
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
Outstanding child and adolescent TB priorities include the need to: find the missing children with active TB and link them to TB care; prevent TB in children who are in contact with infectious TB cases (through implementation of active contact investigation and provision of preventive treatment); an
...
European Union Standards for Tuberculosis Care 2017 Estonian Version
This document aims to provide concrete, pragmatic guidance for how TB modelling and related technical assistance is undertaken to support country decision-making. The target audience for this document are the participants and stakeholders in country-level TB modelling efforts, including the individu
...
This report presents an overview of the transition process in Azerbaijan, some sustainability aspects and challenges stemming from donor withdrawal from TB-related activities, along with recommendations on how to overcome transition-related difficulties and ensure sustainability.
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)
...
Цей документ описує кроки, необхідні для визначення скоригованого інтервалу QT (QTc) в
ході моніторингу ЕКГ пацієнтів, які отримують препарати для лікування ХР ТБ, що
...
People living with HIV who have a low CD4 count are at a much higher risk of falling ill from TB infection than HIV negative people.
It is important to offer both HIV testing to TB patients and TB diagnosis in HIV patients. Early detection and effective treatment are essential to preventing TB
...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac
...
